Global Melanoma Surgeries and Epidemiology - 2016

  • ID: 3692104
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Melanoma Surgeries and Epidemiology – 2016, provides insights into total Melanoma patients on Surgeries in top 7 markets, Melanoma treatable patients, and Melanoma epidemiology in top 7 markets. Epipatients conducted an online survey with Melanoma specialists, oncologists, and Melanoma patients to identify the Melanoma patients in top 7 markets who were treated by Surgeries. The research also identifies total Melanoma patients’ on Surgeries by Melanoma stages.
Melanoma or Skin Cancer patients have surgery (Wide excision, Lymph node dissection) as a part of their treatment since surgery is the main treatment option for most melanomas, and usually cures early stage melanomas. This study accurately determines and forecast Melanoma patients who were on Surgeries in a given year. This research also provides insights into Melanoma epidemiology including Melanoma incidence and Melanoma prevalence by Melanoma stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Melanoma Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Melanoma Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Melanoma Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Melanoma Patients on Surgeries by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Melanoma market potential, Melanoma Surgeries market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Melanoma Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on Surgeries
3. Melanoma Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on Surgeries
4. Melanoma Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on Surgeries
5. Melanoma Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on Surgeries
6. Melanoma Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on Surgeries
7. Melanoma Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on Surgeries
8. Melanoma Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on Surgeries
9. Melanoma Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on Surgeries
10. Glossary

1. Melanoma Incidence by Stages, Global, 2010 - 2025
2. Melanoma Prevalence by Stages, Global, 2010 - 2025
3. Melanoma Treatable Patients by Stages, Global, 2010 - 2025
4. Total Melanoma Patients on Surgeries by Stages, Global, 2010 – 2025
5. Melanoma Incidence by Stages, Germany, 2010 - 2025
6. Melanoma Prevalence by Stages, Germany, 2010 - 2025
7. Melanoma Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Melanoma Patients on Surgeries by Stages, Germany, 2010 - 2025
9. Melanoma Incidence by Stages, France, 2010 - 2025
10. Melanoma Prevalence by Stages, France, 2010 - 2025
11. Melanoma Treatable Patients by Stages, France, 2010 - 2025
12. Total Melanoma Patients on Surgeries by Stages, France, 2010 - 2025
13. Melanoma Incidence by Stages, Italy, 2010 - 2025
14. Melanoma Prevalence by Stages, Italy, 2010 - 2025
15. Melanoma Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Melanoma Patients on Surgeries by Stages, Italy, 2010 - 2025
17. Melanoma Incidence by Stages, Spain, 2010 - 2025
18. Melanoma Prevalence by Stages, Spain, 2010 - 2025
19. Melanoma Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Melanoma Patients on Surgeries by Stages, Spain, 2010 - 2025
21. Melanoma Incidence by Stages, UK, 2010 - 2025
22. Melanoma Prevalence by Stages, UK, 2010 - 2025
23. Melanoma Treatable Patients by Stages, UK, 2010 - 2025
24. Total Melanoma Patients on Surgeries by Stages, UK, 2010 – 2025
25. Melanoma Incidence by Stages, Japan, 2010 - 2025
26. Melanoma Prevalence by Stages, Japan, 2010 - 2025
27. Melanoma Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Melanoma Patients on Surgeries by Stages, Japan, 2010 – 2025
29. Melanoma Incidence by Stages, US, 2010 - 2025
30. Melanoma Prevalence by Stages, US, 2010 - 2025
31. Melanoma Treatable Patients by Stages, US 2010 - 2025
32. Total Melanoma Patients on Surgeries by Stages, US, 2010 - 2025

1. Melanoma Incidence, Global, 2010 – 2025
2. Melanoma Incidence – Stage I, Global, 2010 – 2025
3. Melanoma Incidence – Stage II, Global, 2010 - 2025
4. Melanoma Incidence – Stage III, Global, 2010 - 2025
5. Melanoma Incidence – Stage IV, Global, 2010 – 2025
6. Melanoma Prevalence, Global, 2010 - 2025
7. Melanoma Prevalence – Stage I, Global, 2010 – 2025
8. Melanoma Prevalence – Stage II, Global, 2010 - 2025
9. Melanoma Prevalence – Stage III, Global, 2010 - 2025
10. Melanoma Prevalence – Stage IV, Global, 2010 - 2025
11. Melanoma Treatable Patients, Global, 2010 - 2025
12. Melanoma Treatable Patients – Stage I, Global, 2010 – 2025
13. Melanoma Treatable Patients – Stage II, Global, 2010 - 2025
14. Melanoma Treatable Patients – Stage III, Global, 2010 - 2025
15. Melanoma Treatable Patients – Stage IV, Global, 2010 - 2025
16. Melanoma Patients on Surgeries, Global, 2010 - 2025
17. Total Melanoma Patients on Surgeries – Stage I, Global, 2010 – 2025
18. Total Melanoma Patients on Surgeries – Stage II, Global, 2010 – 2025
19. Total Melanoma Patients on Surgeries – Stage III, Global, 2010 – 2025
20. Total Melanoma Patients on Surgeries – Stage IV, Global, 2010 – 2025
21. Melanoma Incidence by Stages, Germany, 2010 – 2025
22. Melanoma Prevalence by Stages, Germany, 2010 – 2025
23. Melanoma Treatable Patients by Stages, Germany, 2010 – 2025
24. Melanoma Patients on Surgeries, Germany, 2010 - 2015
25. Melanoma Incidence by Stages, France, 2010 – 2025
26. Melanoma Prevalence by Stages, France, 2010 – 2025
27. Melanoma Treatable Patients by Stages, France, 2010 – 2025
28. Melanoma Patients on Surgeries, France, 2010 – 2025
29. Melanoma Incidence by Stages, Italy, 2010 – 2025
30. Melanoma Prevalence by Stages, Italy, 2010 – 2025
31. Melanoma Treatable Patients by Stages, Italy, 2010 – 2025
32. Melanoma Patients on Surgeries, Italy, 2010 – 2025
33. Melanoma Incidence by Stages, Spain, 2010 – 2025
34. Melanoma Prevalence by Stages, Spain, 2010 – 2025
35. Melanoma Treatable Patients by Stages, Spain, 2010 – 2025
36. Melanoma Patients on Surgeries, Spain, 2010 - 2015
37. Melanoma Incidence by Stages, UK, 2010 – 2025
38. Melanoma Prevalence by Stages, UK, 2010 – 2025
39. Melanoma Treatable Patients by Stages, UK, 2010 – 2025
40. Melanoma Patients on Surgeries, UK, 2010 – 2025
41. Melanoma Incidence by Stages, Japan, 2010 – 2025
42. Melanoma Prevalence by Stages, Japan, 2010 – 2025
43. Melanoma Treatable Patients by Stages, Japan, 2010 – 2025
44. Melanoma Patients on Surgeries, Japan, 2010 – 2025
45. Melanoma Incidence by Stages, US, 2010 – 2025
46. Melanoma Prevalence by Stages, US, 2010 – 2025
47. Melanoma Treatable Patients by Stages, US, 2010 – 2025
48. Melanoma Patients on Surgeries, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll